Yunkang Group Limited operates as a medical operation service provider in the People's Republic of China. The company offers diagnostic testing services for medical institution alliances, including setting up or upgrading diagnostic centers, the establishment of standard operating procedures for diagnostic testing, diagnostic consultation and staff training, procurement of equipment, smart internet of things, and logistics assistance. It also provides diagnostic outsourcing services comprising pathology tests; infectious disease diagnostic tests; and genetic reproduction and screening tests. In addition, the company offers routine diagnostic tests for chronic kidney, blood, autoimmune, endocrine metabolism, and other diseases. Further, it provides technology platforms, including AI + healthcare; high-throughput sequencing technology platform; PCR technology platform; digital pathology remote diagnosis platform; and other technology platforms. The company provides its services through independent clinical laboratories and on-site diagnostic centers. Yunkang Group Limited was founded in 2008 and is headquartered in Guangzhou, the People's Republic of China.
Часто задаваемые вопросы
В каком секторе работает Yunkang Group Ltd (2325)?
Yunkang Group Ltd относится к сектору Здравоохранение.
Какова текущая цена акций Yunkang Group Ltd (2325)?
По последним данным, цена акций Yunkang Group Ltd составляет 0,48 HK$, предыдущее закрытие — 0,49 HK$. За последнюю торговую сессию акции Yunkang Group Ltd снизились на -0,01 HK$, что соответствует падению на -2,06%.
Выплачивает ли Yunkang Group Ltd (2325) дивиденды?
Нет, Yunkang Group Ltd не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у Yunkang Group Ltd (2325)?
У компании Yunkang Group Ltd бета -0.798, что указывает на более низкую волатильность по сравнению с рынком в целом.
